Article
MicroRNAs in the Myelodysplastic Syndrome
27 Jul 2021
Abstract excerpt
The myelodysplastic syndrome (MDS) holds a special place among blood cancers, as it represents a whole spectrum of hematological disorders with impaired differentiation of hematopoietic precursors, bone marrow dysplasia, genetic instability and is noted for an increased risk of acute myeloid leukemia. Both genetic and epigenetic factors, including microRNAs (miRNAs), are involved in MDS development. MicroRNAs are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
